Pregled bibliografske jedinice broj: 1054324
Pregnancy with type I diabetes treated with an insulin pump. Risks for large for gestational age infants and alternating basal-bolus insulin ratio
Pregnancy with type I diabetes treated with an insulin pump. Risks for large for gestational age infants and alternating basal-bolus insulin ratio // Diabetes Technology & Therapeutics, Vol. 22, Suppl. 1 (2020)
Larchmont, NY: Mary Ann Liebert, 2020. str. A167-A168 doi:10.1089/dia.2020.2525.abstracts (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1054324 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Pregnancy with type I diabetes treated with an insulin pump. Risks for large for
gestational age infants and alternating basal-bolus insulin ratio
(Pregnancy with type I diabetes treated with an
insulin pump. Risks for large for gestational age
infants and alternating basal-bolus insulin ratio)
Autori
Lekšić, Gloria ; Baretić, Maja ; Ivanišević, Marina ; Jurišić-Eržen, Dubravka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Diabetes Technology & Therapeutics, Vol. 22, Suppl. 1 (2020)
/ - Larchmont, NY : Mary Ann Liebert, 2020, A167-A168
Skup
13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)
Mjesto i datum
Madrid, Španjolska, 18.02.2020. - 22.02.2020
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
type 1 diabetes mellitus ; insulin pump ; pregnancy ; large for gestational age
Sažetak
BACKGROUND AND AIMS: The aim of this study was to identify parameters that contribute the most to the development of large for gestational age (LGA) infants in a cohort of patients with type 1 diabetes mellitus (T1DM) treated with an insulin pump during pregnancy. Furthemore, basal and bolus insulin changes during pregnancy were also evaluated. METHODS: The data of patients was retrospectively analyzed. Inclusion criteria were HbA1c ≤7.0% (53mmol/mol) and BMI<25kg/m2 at the time of conception, duration of T1DM for more than 2 years and treatment with insulin pump for at least 3 months prior to conception. A total of 14 patients were included. Patient characteristics are shown in Table 1. Statistical analysis was performed using Wilcoxon signed ranks test and linear regression. RESULTS: Among several analyzed parameters, only HbA1c in the last trimester was extracted as a significant predictor of birth weight (R square=0.653). Furthermore, preconception maternal body weight correlated with HbA1c in the last trimester (p=0.026, r=0.592). Regarding insulin changes, total daily insulin dose (TDI) increased by 33% from the conception to the last trimester, 34.7U (13.4-50.6) and 46.2 U (17.5-87.0), respectively (Figure 1, Table 1). Most of the TDI increase was attributed to the rise of bolus insulin while basal insulin remained fairly constant with basal-bolus insulin ratio changing from 52/48 to 39/61. CONCLUSIONS: Preconception body weight and optimal glycemic control during pregnancy, especially in the last trimester, are essential for reducing risk of LGA neonates. Regarding insulin changes, there should be emphasis on increase of bolus insulin as pregnancy progresses
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Klinički bolnički centar Rijeka
Profili:
Maja Baretić
(autor)
Gloria Lekšić
(autor)
Dubravka Jurišić-Eržen
(autor)
Marina Ivanišević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE